Brief: Guangzhou Innogen Pharmaceutical Announces Intention To Conduct On-Market H Share Repurchase
26/08/2026 02:30
BRIEF-Guangzhou Innogen Pharmaceutical Announces Intention To Conduct On-Market H Share Repurchase Aug 26 (Reuters) - Guangzhou Innogen Pharmaceutical Group Co Ltd 2591.HK:
INTENTION TO CONDUCT ON-MARKET H SHARE REPURCHASE
ANNOUNCES INTENTION TO REPURCHASE H SHARES UP TO HK$50 MILLION ON-MARKET
Further company coverage: 2591.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Guangzhou Innogen Pharmaceutical
See all newsBrief: Guangzhou Innogen Pharmaceutical Appoints Jin Bai As Vice President
Brief: Guangzhou Innogen Pharmaceutical Says Xu Wenjie Resigns As Executive Director
Brief: Guangzhou Innogen Pharmaceutical Group Co's Founder, Senior Management Undertakes Six-Month Lock-Up
Brief: Guangzhou Innogen Pharmaceutical Announces Intention To Conduct On-Market H Share Repurchase
Brief: GUANGZHOU INNOGEN PHARMACEUTICAL Posts HY LOSS Of RMB115.5 MLN